Skip to main content

Eliezer M Van Allen

NIH Rank #2184
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11913350Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$3.3M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#2,184
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Eliezer M Van Allen. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Eliezer M Van Allen as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA279221-01A1R01
    Dissecting Integrated Cellular Programs Promoting Platinum Resistance and Progression in Bladder Cancer
    $736.8K
    award amount
  • 1R01CA278980-01A1R01
    Dissecting Convergent Somatic and Germline Alterations that Mediate the Origins and Evolution of Kidney Cancer
    $728.8K
    award amount
  • 5P30CA006516-59P30
    Dana-Farber/Harvard Cancer Center
    $509.8K
    award amount
  • 5U2CCA252974-05U2C
    Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
    $489.1K
    award amount
  • 5R37CA222574-07R37
    Molecular origins and evolution to chemoresistance in germ cell tumors
    $391.6K
    award amount
  • 5P50CA272390-02P50
    DF/HCC Prostate SPORE
    $237.8K
    award amount
  • 3R37CA222574-07S1R37
    Molecular origins and evolution to chemoresistance in germ cell tumors
    $233.4K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Eliezer M Van Allen as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2184
  6. 2024
    Entered Top 25% Nationally
    Ranked #2184
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader